NCT04296643

Brief Summary

A randomized controlled trial in which health care workers will be randomized to either medical masks or N95 respirators when providing care to patients with COVID-19.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,009

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Mar 2020

Typical duration for phase_4

Geographic Reach
4 countries

15 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2020

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

March 3, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 5, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2022

Completed
Last Updated

January 12, 2023

Status Verified

January 1, 2023

Enrollment Period

2.3 years

First QC Date

March 3, 2020

Last Update Submit

January 11, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • RT-PCR confirmed COVID-19 infection

    Number of participants with RT-PCR confirmed COVID-19 infection

    10 weeks

Secondary Outcomes (7)

  • Acute respiratory illness

    10 weeks

  • Absenteeism

    10 weeks

  • Lower respiratory infection

    10 weeks

  • Pneumonia

    10 weeks

  • ICU admission

    10 weeks

  • +2 more secondary outcomes

Study Arms (2)

Medical Mask

EXPERIMENTAL

Medical Mask worn when providing care to patient with febrile respiratory illness

Device: Medical Mask

N95 respirator

ACTIVE COMPARATOR

N95 respirator worn when providing care to patient with febrile respiratory illness

Device: N95 respirator

Interventions

Medical Mask (known also as Surgical Mask)

Medical Mask

N95 respirator

N95 respirator

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Health care workers who provide direct care to patients with suspected or confirmed COVID-19 in specialized COVID-19 units and in emergency departments, medical units, pediatric units, and long-term care facilities
  • Health care workers are required to spend 60% or more of their time doing clinical work when enrolled.

You may not qualify if:

  • Unable to pass or do not have a valid fit test within the past 24 months
  • One or more high-risk comorbidities for COVID-19 (hypertension, cardiac disease, pulmonary disease, chronic kidney disease, diabetes, chronic liver disease, actively treated cancer, or immunosuppression due to illness or medications)
  • Previous laboratory confirmed clinical diagnosis of COVID-19 at the time of
  • Received 1 or more doses of a COVID-19 vaccine with greater than 50% efficacy for the circulating strain (for example, mRNA or vector-based COVID-19 vaccine against the original SARS-CoV-2 strain).
  • working in intensive care units.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (15)

Foothills Medical Centre

Calgary, Alberta, T2N 1N4, Canada

Location

University of Alberta Hospital

Edmonton, Alberta, Canada

Location

Brantford General Hospital

Brantford, Ontario, Canada

Location

Hamilton Health Sciences

Hamilton, Ontario, Canada

Location

St. Joseph's Healthcare

Hamilton, Ontario, Canada

Location

Ottawa Hospital

Ottawa, Ontario, K1H 8L6, Canada

Location

Hopital Montfort

Ottawa, Ontario, K1K 0T2, Canada

Location

Niagara Health Services

Saint Catherines, Ontario, Canada

Location

St. Joe's Unity Health

Toronto, Ontario, Canada

Location

St. Mike's Unity Health

Toronto, Ontario, Canada

Location

Montreal University Health Centre

Montreal, Quebec, Canada

Location

The Jewish General Hospital

Montreal, Quebec, Canada

Location

Fayoum General Hospital

Al Fayyum, Egypt

Location

Golden Care LTCF

Tzrifin, Israel

Location

Dr. Ziauddin Hospital

Karachi, Pakistan

Location

Related Publications (2)

  • Loeb M, Bartholomew A, Hashmi M, Tarhuni W, Hassany M, Youngster I, Somayaji R, Larios O, Kim J, Missaghi B, Vayalumkal JV, Mertz D, Chagla Z, Cividino M, Ali K, Mansour S, Castellucci LA, Frenette C, Parkes L, Downing M, Muller M, Glavin V, Newton J, Hookoom R, Leis JA, Kinross J, Smith S, Borhan S, Singh P, Pullenayegum E, Conly J. Medical Masks Versus N95 Respirators for Preventing COVID-19 Among Health Care Workers : A Randomized Trial. Ann Intern Med. 2022 Dec;175(12):1629-1638. doi: 10.7326/M22-1966. Epub 2022 Nov 29.

  • Schunemann HJ, Akl EA, Chou R, Chu DK, Loeb M, Lotfi T, Mustafa RA, Neumann I, Saxinger L, Sultan S, Mertz D. Use of facemasks during the COVID-19 pandemic. Lancet Respir Med. 2020 Oct;8(10):954-955. doi: 10.1016/S2213-2600(20)30352-0. Epub 2020 Aug 3. No abstract available.

MeSH Terms

Conditions

Coronavirus Infections

Interventions

N95 Respirators

Condition Hierarchy (Ancestors)

Coronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsVirus DiseasesInfections

Intervention Hierarchy (Ancestors)

Surgical AttireEquipment and Supplies, HospitalEquipment and SuppliesRespiratory Protective DevicesPersonal Protective EquipmentProtective DevicesSurgical EquipmentManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Mark B Loeb

    McMaster University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Investigators and laboratory assessors were blinded to the group assignment, but it was not possible to conceal the identity of the medical mask or N95 respirator assignment to the study staff or participants.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: pragmatic, randomized, open-label, multicentre, noninferiority trial.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2020

First Posted

March 5, 2020

Study Start

March 1, 2020

Primary Completion

June 1, 2022

Study Completion

December 8, 2022

Last Updated

January 12, 2023

Record last verified: 2023-01

Locations